The Tale of Big Pharma- Bayer (IG Farben), FDA and the AIDS virus
Bayer paid hundreds of millions of dollars to end a three-decade-long scandal in which the company sold HIV-contaminated blood to hemophiliacs, thousands of whom later died of AIDS.
Milos Pokimica
Written By: Milos Pokimica
Medically Reviewed by: Dr. Xiùying Wáng, M.D.
Updated August 4, 2023Nutritional science explained all of the connections between diseases of affluence and animal food consumption decades ago. Most of our number one killers are preventable but there is no interest in changing the current line of business. All of the available science will be kept out of the public and in reality, it does not matter.
What most people are aware of is just propaganda. Doctors are good, they have to pledge a Hippocratic oath, there are there to heal you and help you, and of course one day medicine is going to deliver us from all diseases. Usually, when people are confronted with the real history behind big pharma and realize the truth that government itself has a network for suppressing the science and that individual men’s interest is not its primary goal, they usually say that it is all in the past. Today we have more democracy and freedoms with better governmental control and so on.
The answer is no. We have even fewer freedoms than after WW2. We have been brainwashed in schools and by the media infused with psychological research for social control, but nothing else is different. The same structure exists and has been existing from not just middle age but even before that.
I will give one more recent example. You’d probably never know that Bayer (IG Farben) paid “tens of millions” of dollars to end a three-decade-long scandal in which the company sold HIV-contaminated blood products to hemophiliacs, thousands of whom later died of AIDS. Bayer is eventually forced into signing checks to individuals that acquired AIDS because, in the 1980s, the Cutter Biological section of Bayer neglected federal law and recruited gay men with high risk and intravenous drug users, and prisoners as donors of the blood that Cutter later used to produce Factor VIII and IX. It is a drug, the clotting product, that hemophiliacs need in order to not bleed to death. In 1997 Bayer was sentenced to pay 600 million into a compensation fund for hemophiliacs with HIV. About 20,000 individuals caught HIV from the blood.
Ironically, Bayer’s new hemophilia iPhone app got some coverage, as did Bayer’s hemophilia research grant to the University of Florida.
On July 16, 1982, the United States Centers for Disease Control and Prevention (CDC) suggested that three hemophiliacs had acquired AIDS. Epidemiologists began to think that the virus was spreading through hemophiliac medication that they inject once every week. Medication was made from large pools of donated plasma from different people. Much of which was collected before mandatory HIV testing, often from homosexuals and drug users and in some prisons. Without an infection test, they had no way to determine does the plasma donors carried the virus. In January 1983, the manager of Bayer’s Cutter Biological department confirmed in a letter that:
“There is strong evidence to suggest that AIDS is passed on to other people through … plasma products.”
These letters surfaced in trials and were found by some of the investigative journalists that later broke the story public. By May 1983, a Cutter competitor started producing a heat-treated concentrate that killed the virus, so France for example, and many other countries decided to halt all clotting concentrate imports. Cutter worried about losing consumers, so according to an enclosed memo: “want to give the impression that we continue improving our product without telling them that soon we were also going to have a heat-treated” concentrate. By June 1983, a Cutter letter to distributors to 20 countries said that:
“AIDS has become the center of irrational response in many countries” and that “This is of particular concern to us because of unsubstantiated speculations that certain blood products may transmit this syndrome.”
They lied, and many countries were still using an old concentrate. In February 1984, Cutter became the last of the four major blood product companies to get US approval to sell heated concentrate. They waited as long as possible. Still even after Cutter started to sell the new product, still for several more months, they continued making the old medicine. The reason was that the corporation had several fixed-price contracts and thought that the old product would be cheaper to produce. Bayer officials (responding on behalf of Cutter) responded with another lie: “because some customers doubted the new drug’s effectiveness,” some nations were slow to support registration of the new drug. Then they lied by telling that they had a shortage of plasma, which is used to make the medicine. For example, Taiwan was one country that still received the old HIV-infected drug. Hsu Chien-wen, an official at Taiwan’s health department, told in 2003 that Cutter had not appealed for approval to sell the heated medicine until July 1985. That was for an entire year and a half after doing so in the United States. In Hong Kong, for example, Cutter did not even need approval but only an import license in the 1980s to be able to import and sell the newer product in which normally takes one week. A company meeting notes that:
“There is excess inventory,”
that, in reality, produced the company resolving to:
“Review international markets again to determine if more of this product can be sold.”
Because of the lack of control and corruption Cutter decided to dispose of stockpiles of older HIV-positive drugs to third world countries while selling the new, safer product in the West. If some of the people catch AIDS well, they can take Aspirin for pain. And of course, there are all third world countries, so it is going to go well with eugenic programs of depopulation of the planet. When hemophiliacs in Hong Kong all of the sudden start to test positive for HIV, local physicians raised the question of whether Cutter was dumping “AIDS tainted” medicine into less-developed countries. Cutter rejected the accusation, insisting that older drug had “no severe hazard risk” and was, in fact, the “same fine product we have supplied for years.” Hong Kong did not believe the lie, and when the local distributor asked for the newer product, Cutter responded that all of the new product was going to the US and Europe. For Hong Kong, and other third-world countries they could make an exception for a small amount for the “most vocal patients.” Meaning influential people that could potentially make a problem for them. So if you are a son of a politician, they will give you new safe stuff.
The United States Food and Drug Administration helped to keep the news out of the public eye. Government is not there to protect you and never had been. In May 1985, the FDA’s regulator of blood products, Harry M. Meyer Jr., considering the companies had violated a voluntary arrangement to remove the old drug from the market, called directors of the corporations and directed them to comply. Cutter’s internal notes from their meeting show that Meyer required that the issue is:
“Quietly solved without alerting the Congress, the medical community and the public”
also noted that the FDA wanted the matter solved “quickly and quietly.” Also at that time, Cutter official wrote that:
“It appears there are no longer any markets in the Far East where we can expect to sell substantial quantities of nonheated-treated medicine.”
They sell AIDS-tainted medicine as long as possible with no empathy. The effects of all of this are impossible to calculate because there was no test for HIV, so we do not know how many people were infected with HIV before Cutter began selling its safer medicine or afterward. Cutter also sold the old medicine in Argentina, Indonesia, Japan, Malaysia, and Singapore after February 1984. Cutter shipped more than 100,000 vials of unheated concentrate, worth more than $4 million after it began selling the safer product. The sales continued partly because of Cutter’s desire to deplete stocks of the older medicine, and partly because of fixed-price contracts, for which the company believed the older product would be cheaper to make. U.S. Justice Department had never investigated any corporate executives. Bayer in the past even marketed heroin for children. That is the level of psychopathic nature of these people.
References:
Passages selected from a book: Pokimica, Milos. Go Vegan? Review of Science Part 2. Kindle ed., Amazon, 2018.
- McHenry L, Khoshnood M. Blood money: Bayer’s inventory of HIV-contaminated blood products and third world hemophiliacs. Account Res. 2014;21(6):389-400. doi: 10.1080/08989621.2014.882780. PMID: 24785997.
- Josefson D. Haemophilia patients launch action against Bayer over contaminated blood products. BMJ. 2003 Jun 14;326(7402):1286. doi: 10.1136/bmj.326.7402.1286-g. PMID: 12805147; PMCID: PMC1151015.
Related Posts
Do you have any questions about nutrition and health?
I would love to hear from you and answer them in my next post. I appreciate your input and opinion and I look forward to hearing from you soon. I also invite you to follow us on Facebook, Instagram, and Pinterest for more diet, nutrition, and health content. You can leave a comment there and connect with other health enthusiasts, share your tips and experiences, and get support and encouragement from our team and community.
I hope that this post was informative and enjoyable for you and that you are prepared to apply the insights you learned. If you found this post helpful, please share it with your friends and family who might also benefit from it. You never know who might need some guidance and support on their health journey.
– You Might Also Like –

Learn About Nutrition
Milos Pokimica is a doctor of natural medicine, clinical nutritionist, medical health and nutrition writer, and nutritional science advisor. Author of the book series Go Vegan? Review of Science, he also operates the natural health website GoVeganWay.com
Medical Disclaimer
GoVeganWay.com brings you reviews of the latest nutrition and health-related research. The information provided represents the personal opinion of the author and is not intended nor implied to be a substitute for professional medical advice, diagnosis, or treatment. The information provided is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE OR DELAY SEEKING MEDICAL TREATMENT BECAUSE OF SOMETHING YOU HAVE READ ON OR ACCESSED THROUGH GoVeganWay.com
NEVER APPLY ANY LIFESTYLE CHANGES OR ANY CHANGES AT ALL AS A CONSEQUENCE OF SOMETHING YOU HAVE READ IN GoVeganWay.com BEFORE CONSULTING LICENCED MEDICAL PRACTITIONER.
In the event of a medical emergency, call a doctor or 911 immediately. GoVeganWay.com does not recommend or endorse any specific groups, organizations, tests, physicians, products, procedures, opinions, or other information that may be mentioned inside.
Editor Picks –
Milos Pokimica is a doctor of natural medicine, clinical nutritionist, medical health and nutrition writer, and nutritional science advisor. Author of the book series Go Vegan? Review of Science, he also operates the natural health website GoVeganWay.com
Latest Articles –
Plant Based News
-
Company Makes ‘Ultra-Realistic’ Vegan Meat Using Tech Inspired By Textile Manufacturing
on January 28, 2025
-
Vegan Quinoa Bowl With Tofu Feta
on January 28, 2025
-
Gordon Ramsay Partners With Flora For ‘Skip the Cow’ Campaign
on January 28, 2025
-
Human Case Of Bird Flu Confirmed In England
on January 28, 2025
-
Vegan KitKat Discontinued In All But One Country
on January 28, 2025
-
High-Protein Savory Vegan Muffins
on January 27, 2025
-
Violife Launches Lentil-Based Coffee Creamer
on January 27, 2025
Top Health News — ScienceDaily
- Individual cells can be connected to plastic electrodeson January 28, 2025
Researchers have succeeded in creating a close connection between individual cells and organic electronics. The study lays the foundation for future treatment of neurological and other diseases with very high precision.
- People with schizophrenia have an altered ability to visually perceive contraston January 28, 2025
Schizophrenia is a serious mental disorder that affects around 1% of the world’s population. Researchers have identified a deficit in contrast perception in people with schizophrenia. According to a review of more than 600 studies, these patients have an impaired ability to see differences in light intensity between adjacent areas, which allows us to identify shapes, textures and details in the environment.
- Innovative one-minute video game boasts 80% success rate in diagnosing autismon January 28, 2025
A new one-minute video game is able to accurately and efficiently identify children with autism from those who have ADHD or are neurotypical.
- How simple prompts can make partially automated cars saferon January 28, 2025
A new study finds that prompts do a good job of getting drivers to engage with their environment and take over control of the vehicle when necessary while using partially automated driving systems — with one exception. If drivers are deeply distracted, these system-generated prompts have little or no effect.
- Simple ways to improve the wellbeing of pediatric critical care staffon January 28, 2025
Researchers have developed two simple, easy-to-deliver sessions to improve the wellbeing of staff in pediatric critical care (PCC) units in UK hospitals.
- First mouse with two male parents to reach adulthoodon January 28, 2025
A team of stem cell scientists have successfully used embryonic stem cell engineering to create a bi-paternal mouse — a mouse with two male parents — that lived until adulthood. Their results describe how targeting a particular set of genes involved in reproduction allowed the researchers to overcome previously insurmountable challenges in unisexual reproduction in mammals.
- Strategic corporate social responsibility can create social, economic valueon January 28, 2025
Strategic corporate social responsibility (CSR) efforts that are directly related to a hospitality company’s core business operations and competencies can help companies create both social and business value, according to researchers.
PubMed, #vegan-diet –
- Chia (Salvia hispanica) Seed Oil Modulates the Haemato-Immunological Response, Antioxidative Status and Cytokine Gene Expression of Tropical Freshwater Teleost, Labeo rohitaon January 25, 2025
The present investigation attempts to evaluate the impact of the dietary inclusion of chia (Salvia hispanica) seed oil (CSO) on the indices of haemato-immunology, metabolic enzymes, and expression of immune-responsive cytokine genes in Labeo rohita (rohu) fingerlings. The responses were observed in a 60-day feeding trial, set up with a total of 180 rohu fingerlings (19.74 ± 0.33 g) randomly allocated to four treatment groups with three replicates each. The groups were fed with a basal diet…
- The Treatment Experiences of Vegetarians and Vegans with an Eating Disorder: A Qualitative Studyon January 25, 2025
CONCLUSIONS: This paper identifies the complex relationship between eating disorders, veganism, and vegetarianism and the perceptions of treatment from the perspectives of those who have received treatment. Our findings suggest that acknowledgement and the flexibility to work with an individual’s vegan and vegetarian values within treatment may contribute to enhanced outcomes and treatment experiences. Limitations include potential participation and response biases and a predominantly…
- Eating to live well-Or worse? The role of vegan and vegetarian diets in mental healthon January 24, 2025
CONCLUSION: The current evidence suggests that if a nutritionally adequate diet is consumed, the avoidance/consumption of meat and other animal foods will have no significant effects on physical and mental health.
- Are Dietary Patterns Relevant for Reducing the Risk of Fractures and Sarcopenia?on January 23, 2025
PURPOSE OF REVIEW: This review aims to summarise recent evidence on the effects of dietary patterns on the risk of bone fractures and sarcopenia.
- International expert consensus on micronutrient supplement use during the early life courseon January 20, 2025
CONCLUSION: The findings revealed robust consensus on various aspects of maternal nutrition, including the need for education, the lack of consistency in current guidelines on supplement use, the importance of supplement use across specific phases of pregnancy and the at-risk groups requiring tailored approaches.
Random Posts –
Featured Posts –

Latest from PubMed, #plant-based diet –
- A better diet quality based on the Healthy Eating Index-2020 is associated with lower energy intake and age but not with a pre-diabetes/T2DM diagnosis among Hispanic women with overweight/obesityby Mayra Arias-Gastélum on January 28, 2025
Low diet quality is related to obesity and type 2 diabetes mellitus (T2DM) risk among Hispanic women. This cross-sectional study compared diet quality among Hispanic women with overweight/obesity based on their T2DM diagnosis (pre-diabetes/T2DM group, n = 104 vs no diagnosis, at-risk group, n = 84). It was hypothesized that having a pre-diabetes or T2DM diagnosis would be associated with better diet quality based on the Healthy Eating Index (HEI)-2020 score. Means were compared using a […]
- The impact of dietary patterns on gut microbiota for the primary and secondary prevention of cardiovascular disease: a systematic reviewby Junwen Yu on January 28, 2025
CONCLUSIONS: Different dietary patterns showed distinct impacts on gut microbiota composition. Plant-rich diets promoted the proliferation of butyrate-producing bacteria, suggesting promising prospects for modulating gut microbiota and butyrate production through dietary interventions to enhance cardiovascular health. Further research is warranted to investigate the long-term effects of dietary patterns on clinical endpoints, such as CVD events or mortality.
- Which dietary shifts to improve nutritional quality while reducing diet cost in the French West Indies?by Marlène Perignon on January 28, 2025
CONCLUSIONS: Nutrition prevention programs promoting the affordable and nutritious dietary shifts identified in the present study, i.e. reduction in animal flesh foods (meat, fish) as well as refined cereals and sweet products in favour of an increase in healthy plant-based foods and animal co-products (dairy, eggs), could help improve nutritional adequacy of the Guadeloupean and Martinican populations.
- Multidimensional Assessment of Orthorexia Nervosa: A Case-Control Study Comparing Eating Behavior, Adherence to the Mediterranean Diet, Body Mass Index, Psychological Symptoms, and Autonomic Arousalby Sara Guidotti on January 25, 2025
Background: The research on orthorexia nervosa (ON) has thoroughly outlined the connection between it and various mental disorders, including obsessive-compulsive disorders and eating disorders, in addition to stress. However, research has not considered psychophysical stress and other measures of psychophysical health, such as adherence to the Mediterranean diet. Methods: This cross-sectional and case-control research involved 63 students from the University of Parma, aged between 18 and 49…
- The Relationship Between a Mediterranean Diet and Frailty in Older Adults: NHANES 2007-2017by Danae C Gross on January 25, 2025
CONCLUSIONS: Mediterranean diet adherence is associated with decreased odds of frailty in older adults. These findings suggest that adherence to a Mediterranean diet may play a critical role in mitigating frailty and its associated conditions. Future research should include longitudinal and interventional studies that can definitively determine the effect of a Mediterranean diet on frailty and what food components provide the greatest benefit.
- The Role of Maintaining Nutritional Adequacy Status and Physical Activity in Onco-Nephrology: Not a Myth Anymore, but a Realityby Francesco Trevisani on January 25, 2025
Background: Physical Activity (PA) provides numerous biological and psychological benefits, especially for cancer patients. PA mitigates treatment side effects, influences hormones, inflammation, adiposity, and immune function, and reduces symptoms of anxiety, depression, and fatigue. This study evaluates the impact of PA on these positive outcomes. Materials and Methods: An observational retrospective study enrolled 81 patients: 31 with CKD stages II-V and 50 with CKD and urological…